Dr David Rudolf Hafermann, MD | |
280 Homeolu Place, Kaunakakai, HI 96748 | |
(808) 553-3121 | |
Not Available |
Full Name | Dr David Rudolf Hafermann |
---|---|
Gender | Male |
Speciality | Internal Medicine - Pulmonary Disease |
Location | 280 Homeolu Place, Kaunakakai, Hawaii |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235211285 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | MD-12390 (Hawaii) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr David Rudolf Hafermann, MD Po Box 1922, Kaunakakai, HI 96748-1922 Ph: (808) 553-3573 | Dr David Rudolf Hafermann, MD 280 Homeolu Place, Kaunakakai, HI 96748 Ph: (808) 553-3121 |
News Archive
Five additional pharmaceutical companies have joined a National Institutes of Health-led effort to help scientists research promising new treatments for patients. Funding and molecular compound information is available now for the initial phase of the recently unveiled Discovering New Therapeutic Uses for Existing Molecules program.
With the help of genetically engineered mice, scientists at the Massachusetts General Hospital are moving closer to establishing the role that increased intestinal permeability, sometimes called a "leaky gut," plays in chronic inflammatory conditions.
My wife and I attended my 30-year college reunion a couple of weekends ago, but the partying was bittersweet. My freshman roommate, Scott Androes, was in a Seattle hospital bed, a victim in part of a broken health care system. Strip away the sound and fury of campaign ads and rival spinmeisters, and what's at stake in this presidential election is, in part, lives like Scott's. ... Scott now, at age 52, is suffering from Stage 4 prostate cancer, in part because he didn't have health insurance.
Two women have become the first to die from H1N1 (swine flu) in Gaza, health officials said Monday, Agence France-Presse/Inquirer.net reports. The announcement came after five patients were confirmed to have H1N1 - the first cases in the region.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumors, today announced the initiation of the first clinical study to evaluate the use of the Calypso System for tracking lung cancer tumors during radiation delivery, including a new design of the Company's implantable Beacon transponder.
› Verified 5 days ago
Peter Lung-sang Chan, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 9 Hooulu Place, Kaunakakai, HI 96748 Phone: 808-553-3086 | |
Carlann Defontes, D.O. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 280 Home Olu Place Va Clinic ,, Paul Stevens Outpatient Clinic, Molokai General Hospita, Kaunakakai, HI 96748 Phone: 808-553-3121 | |
Phillip Waiholo Reyes, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 39 Ala Malama, Kaunakakai, HI 96748 Phone: 808-553-5353 Fax: 808-553-4269 | |
Sandra Brazzel, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 280 Homeolu Place, Kaunakakai, HI 96748 Phone: 808-553-3121 Fax: 808-553-3112 |